Quantcast
Channel: MassDevice
Browsing all 11157 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

5 Ways to Make Onboarding Sales Reps More Effective

By Jennifer Kady, Marketing Executive, Allego Attracting the right candidates for sales positions takes skill and persistence, but keeping your new hires happy and engaged can be even more challenging....

View Article


Image may be NSFW.
Clik here to view.

Cochlear shares dip despite huge gains in profit for FY2016

Cochlear Ltd. (ASX:COH) saw shares sag despite releasing fiscal year 2016 earnings today that showed annual net profit growing 30% while overall sales were up almost 25%. The Australian hearing aid...

View Article


Image may be NSFW.
Clik here to view.

Texas adds $4m to Fe3’s Series B round

Transdermal therapy start-up Fe3 Medical picked up a $3.5 million addition to its Series B funding round from the state of Texas bringing its total for the round up to $14.5 million, according to a...

View Article

Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for August 9, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article

Image may be NSFW.
Clik here to view.

ConforMIS Q2 beats the street, raises guidance

ConforMIS (NSDQ:CFMS) released 2nd quarter earnings that slimly topped Wall Street’s expectations, seeing shares dip slightly in response. The Bedford, Mass.-based company reported losses of $14.1...

View Article


Image may be NSFW.
Clik here to view.

Accuray wins CE Mark for Radixact platform

Accuray (NSDQ:ARAY) said today it won CE Mark approval in the European Union for its Radixact treatment delivery platform designed for image-guided radiotherapy treatments designed for cancer patients....

View Article

Image may be NSFW.
Clik here to view.

Synapse Biomedical wins VA nod for NeuRx diaphragm pacing system

Synapse Biomedical said today it won a GSA schedule 65IIA contract which will allow it to supply its NeuRX diaphragm pacing system to Veterans Affairs hospitals. The Oberlin, Ohio-based company said...

View Article

Image may be NSFW.
Clik here to view.

FDA clears Centric Medical’s hammertoe device

Centric Medical, the foot & ankle division of Life Spine, said today it won FDA 510(k) clearance for its Hammertoe Correction System. The newly cleared system is designed to be inserted between the...

View Article


Image may be NSFW.
Clik here to view.

Nevro losses shrink, sales explode in Q2

Nevro Corp. (NYSE:NVRO) saw shares soar after reporting a significant 2nd quarter yesterday, with losses shrinking by more than 50% while sales exploded nearly 400%, causing the company to lift its...

View Article


Image may be NSFW.
Clik here to view.

Updated FDA recommendations for when medical device changes require new 510(k)s

By Stewart Eisenhart, Emergo Group US medical device regulators have issued new recommendations for determining when changes to a registered medical device require filing a new 510(k) application. The...

View Article

Image may be NSFW.
Clik here to view.

Apple CEO Cook: Healthcare may make smartphone market ‘look small’

Apple (NSDQ:AAPL) CEO Tim Cook says that the healthcare market’s potential could dwarf the smartphone market that accounts for some 65% of Apple’s $234 billion in annual revenues. The consumer...

View Article

Image may be NSFW.
Clik here to view.

UPDATE: Private equity players prep nearly $1B offering of Zimmer Biomet shares

UPDATED August 10, 2016, with information on the pricing and closing date for the offering. A pair of private equity players are readying an offering of Zimmer Biomet (NYSE:ZBH) shares that could be...

View Article

Image may be NSFW.
Clik here to view.

Medicrea raises $22m, taps Globus Medical co-founder Kienzle

Medicrea (EPA:ALMED) said it raised a funding round worth about $22.3 million for its UniD patient-specific spinal rod technology and tapped GMEd co-founder Richard Kienzle as its new chief commercial...

View Article


Image may be NSFW.
Clik here to view.

Neovasc shares tumble on Q2 release with $70m set aside to cover loss to...

Neovasc (NSDQ:NVCN) shares have plummeted nearly 20% after saying it set aside $70 million to cover a loss in an ongoing patent battle with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve...

View Article

Image may be NSFW.
Clik here to view.

What Exactly Is Sales Enablement?

By Jennifer Kady, Marketing Executive, Allego What is sales enablement? Simply put, it’s a role that helps sales teams to be more productive. Gartner defines it as, “The activities, systems, processes...

View Article


Image may be NSFW.
Clik here to view.

FDA draft guidance on 510(k)s omits combination devices

Combination medical devices which bring together device components and drugs or biological products into a single unit are missing from new draft guidance from the FDA. The guidance, released last...

View Article

Image may be NSFW.
Clik here to view.

Alere: Abbott can’t get out of $6B merger

Alere (NYSE:ALR) said it is confident it’s potential $6 billion merger with Abbott (NYSE:ABT) will go through, despite concerns that it could fall through. “In response to the statements made by an...

View Article


Image may be NSFW.
Clik here to view.

Spectranetics wins CE Mark for AngioSculptX drug-coated ‘scoring’ balloon

Spectranetics (NSDQ:SPNC) said today it won CE Mark approval in the European Union for its AngioSculptX drug-coated PTCA scoring balloon catheter designed to treat coronary artery stenosis. The device...

View Article

Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for August 10, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article

Image may be NSFW.
Clik here to view.

Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and...

The FDA issued the guidance “Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act” on May 16th, 2016.  Section 522 of the FD&C Act provides the FDA with the...

View Article
Browsing all 11157 articles
Browse latest View live


Latest Images